Biotechnology Products Companies in China
- ASI3276430
- 147 Pages
- October 2019
- Pharmaceuticals
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
I. EXECUTIVE SUMMARY
Report Scope and Methodology
Executive Summary
III. BIO INDUSTRY ASSESSMENTS
Bio Industry Structure
Market Size
Market Growth Drivers
Bio Industry Capacity
Major Producer Facility Locations, Output and Capacity
Market Share of Key Producers
Market Distribution and Marketing Strategies
Overview
Market Distribution
Marketing Strategies
Product Patent
Overview
History of China Bio-product Patent Application
Analysis of China Bio-product Patent Application Situation
Related Laws and Regulations about Bio-product Patent Application in China
Potential Market Entrance
Overview
Potential Market Entrance
Analysis of China Pharmaceutical Market Entrance Situation
VII. BIO PRODUCT PRODUCER DIRECTORY
Bio Product Producer Profiles
U UUUULIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
III. BIO INDUSTRY ASSESSMENTS
Bio Products Industry Capacity and Output in China
Diagnosis Production and Demand
Biopharmaceuticals Production and Demand
Biomedical Materials Production and Demand
Bio Products Industry Demand in China
China’s Bio Industry Capacity by Classification
Major Bio Products Producers’ Output, Capacity and Location
Major Diagnosis Producers’ Output, Capacity and Location
Major Biopharmaceuticals Producers’ Output, Capacity and Location
Major Biomedical Materials Producers’ Output, Capacity and Location
Market Share of Diagnosis Key Producers
Market Share of Biopharmaceuticals Key Producers
Market Share of Biomedical Materials Key Producers
China’s Major Bio Products Distributors and Their Locations
U UUUULIST OF CHARTS
I. INTRODUCTION
China’s Bio Products Capacity, Output, Demand
III. BIO INDUSTRY ASSESSMENTS
Bio Products Industry Capacity and Output in China
China’s Diagnosis Consumption by Products
China’s Biopharmaceuticals Consumption by Products
China’s Biomedical Materials Consumption by Products
Bio Products Industry Demand in China
Diagnosis Demand by Classification
Biopharmaceuticals Demand by Classification
Biomedical Materials Demand by Classification
Bio Capacity by Classification
China's Diagnosis Capacity
China's Biopharmaceuticals Capacity
China's Biomedical Materials Capacity
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
